[{"AccountsPayableCurrent_0_Q3_USD":7722000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":3000.0,"OtherAssetsNoncurrent_0_Q3_USD":2373000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":2758000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.043,"OperatingLeaseRightOfUseAsset_0_Q3_USD":60032000.0,"OperatingLeasePayments_3_Q3_USD":3423000.0,"OperatingLeasePayments_1_Q3_USD":1713000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":57677000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":8150000.0,"OperatingLeaseLiability_0_Q3_USD":65827000.0,"OperatingLeaseCost_3_Q3_USD":7016000.0,"OperatingLeaseCost_1_Q3_USD":2014000.0,"OperatingIncomeLoss_3_Q3_USD":-125782000.0,"OperatingIncomeLoss_1_Q3_USD":-15301000.0,"NetIncomeLoss_3_Q3_USD":-124776000.0,"NetIncomeLoss_1_Q3_USD":-14457000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-102540000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-142651000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":13797000.0,"LiabilitiesCurrent_0_Q3_USD":88218000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":717673000.0,"Liabilities_0_Q3_USD":150718000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":14109000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1848000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":8482000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":8275000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":8355000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":6000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-39000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-37000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-41000.0,"StockholdersEquity_0_Q3_USD":566955000.0,"ShareBasedCompensation_3_Q3_USD":50735000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":290116000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":81666000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":17543000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q3_USD":166000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":353387000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":131612000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2110482000.0,"RestrictedCashNoncurrent_0_Q3_USD":5770000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":172473000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":58565000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":8581000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":8701000.0,"ProfitLoss_3_Q3_USD":-124776000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":13797000.0,"PrepaidExpenseCurrent_0_Q3_USD":24622000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1121000.0,"PaymentsToAcquireAvailableForSaleSecurities_3_Q3_USD":453847000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":706000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":383000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":4823000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-43000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":312317000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":79936000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":533913000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":6670000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-14495000.0,"CommonStockValue_0_Q3_USD":16000.0,"CommonStockSharesOutstanding_0_Q3_shares":160690916.0,"CommonStockSharesIssued_0_Q3_shares":160690916.0,"CommonStockSharesAuthorized_0_Q3_shares":225000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-231388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":100410000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":94640000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":445651000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q3_USD":257337000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":40000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-124813000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q3_USD":257337000.0,"AssetsCurrent_0_Q3_USD":640917000.0,"Assets_0_Q3_USD":717673000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":18569000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1108000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":400000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":50735000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":15546000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2677422000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-1000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":16866000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":80496000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1766000.0,"AccountsReceivableNetCurrent_0_Q3_USD":60696000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":40000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":160663000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":3688000.0,"CostsAndExpenses_1_Q3_USD":146913000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":6217000.0,"InventoryNet_0_Q3_USD":14336000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":1449000.0,"InterestReceivableCurrent_0_Q3_USD":972000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":462000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":129000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-1072000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-357000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-11000.0,"IncreaseDecreaseInInventories_3_Q3_USD":4427000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-17260000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_3_Q3_USD":-1063000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":12449000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":8399000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-771000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-332000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-124614000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-14789000.0,"GainLossOnInvestments_3_Q3_USD":706000.0,"EquitySecuritiesFvNiCost_0_Q3_USD":445663000.0,"EquitySecuritiesFvNi_0_Q3_USD":445651000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":21783000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":6000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.78,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.09,"Depreciation_3_Q3_USD":1701000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q3_Security":32.0,"CostsAndExpenses_3_Q3_USD":479169000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":162000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":159651000.0,"Ticker":"ACAD","CIK":"1070494","name":"ACADIA PHARMACEUTICALS INC","OfficialName":"ACADIA Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3501345407.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]